ConductScience.org, home

Cell line · CVCL_0465

OVCAR-3

Cancer cell line, Homo sapiens. High grade ovarian serous adenocarcinoma. 234 papers.

4 sourcescell-lines-2026-11-14-0.1.0

Download JSON
Cite this record

ConductScience Library. OVCAR-3. Cell lines, record CVCL_0465. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0465

On this page

Cell line

As Cellosaurus gives it.

Name
OVCAR-3
Accession
CVCL_0465
RRID
RRID:CVCL_0465
Synonyms
Ovcar-3, OVCAR 3, OVCAR.3, NIH:OVCAR-3, NIH:Ovcar-3, NIH:OVCAR3, NIH-OVCAR-3, NIHOVCAR3, OVCAR3, Ovcar3
Species
Homo sapiens (Human)
Sex
Female
Age at sampling
60Y
Category
Cancer cell line
Diseases
High grade ovarian serous adenocarcinoma (NCIt C105555)
Derived from
Ascites (metastatic)
Entry created
2012-04-04
Entry updated
2026-06-25

Source Cellosaurus

Problems0

Cellosaurus records no problem for this cell line.

None in this release.

Papers234

3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

PaperJournalYearHow we knowRetractedSource
Hsa_Circ_0000615-Encoded 250-Amino Acid Polypeptide Suppresses Epithelial Ovarian Cancer Progression via Promoting HMGB1 Nuclear Accumulation.Oncol Res2026Its Methods give the RRID and name the linePubMed
Exosomal circ_0000387 Is Associated With Ovarian Cancer Metastatic Regulation Through IGF2BP3-Related Signalling and Endothelial VWF Responses.J Biochem Mol Toxicol2026Its Methods give the RRID and name the linePubMed
Boosting ovarian cancer immunotherapy via discoidin domain receptor 2 blockade and CD28 x mucin 1 bispecific antibodies.BMC Med2026Its Methods give the RRID and name the linePubMed
Distinct and Convergent Roles of the Synovial Sarcoma X Breakpoint Family of Cancer-Testis Antigens in Ovarian Cancer.Int J Mol Sci2026Its Methods give the RRID and name the linePubMed
Extracellular vesicle lipidomics liquid biopsy reveals systemic and tumor microenvironment metabolic reprogramming in ovarian cancer.Mol Oncol2026Its Methods give the RRID and name the linePubMed
A membrane-penetrating modified ascites-derived peptide, TAT-CPAP1, sensitizes TP53 wild-type ovarian cancer cells to platinum-based therapy through targeting the NOLC1-MDM2/MDM4 axis.Transl Oncol2026Its Methods give the RRID and name the linePubMed
A guide to selecting high-performing antibodies for Netrin-1 (UniProt ID: O95631) for use in western blot and immunoprecipitation.F1000Res2026Its Methods give the RRID and name the linePubMed
Scalable generation of hematopoietic stem cell-engineered off-the-shelf mono-specific cytotoxic T cells targeting solid tumors.Cell Rep Med2026Its Methods give the RRID and name the linePubMed
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells.Cancer Immunol Res2026Its Methods give the RRID and name the linePubMed

1 to 10 of 234

See all 234 papers

Relatives19

RelationCell lineAccessionProblemSource
Derived from itEDITGENE OVCAR-3-CopGFPCVCL_F5ZQCell lines
Derived from itEDITGENE OVCAR-3-FLUCCVCL_F5S8Cell lines
Derived from itHyCyte OVCAR-3-Luc-GFPCVCL_E3I9Cell lines
Derived from itONCO-DG-1CVCL_1882Has a recorded problemCell lines
Derived from itOV(hyg)CAR3CVCL_Y033Cell lines
Derived from itOVCAR-3 SimpleCell O-GalNAcCVCL_S033Cell lines
Derived from itOVCAR-3-LucCVCL_C8Y2Cell lines
Derived from itOVCAR-3/CMV-LucCVCL_4Y18Cell lines
Derived from itOVCAR-3/T40CVCL_DA03Cell lines
Derived from itOVCAR-3/TxT5CVCL_DA02Cell lines

Cell banks17

Cell bankCatalog numberStatusSource
ATCCHTB-161ATCC
Abcamab275471Abcam
BCRC60551BCRC
BCRJ0317BCRJ
CCTCCGDC0119Cellosaurus
CLS300307CLS
EDITGENEEDC00210EDITGENE
ICLCHTL97004DiscontinuedCellosaurus
IZSLERBS TCL 131Cellosaurus
KCBKCB 2006106YJCellosaurus

Data dates

The date of each source this release read.

Cellosaurus
2026-10-22
Cellosaurus
PubMed Central's articles
2026-11-12
PubMed Central's articles
Our copy of PubMed
2026-11-06
Our copy of PubMed

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this cell line from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0465

GET https://conductscience.org/api/cell-lines/v1/CVCL_0465/papers?page=2